Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kyowa Pharmaceutical Industry Co. Ltd.

Division of Lupin Ltd.
www.kyowayakuhin.co.jp/en

Latest From Kyowa Pharmaceutical Industry Co. Ltd.

Oncology Stakeholders Offer Niche Recommendations To US FDA, But Who Will Ultimately Get Their Way?

Advocates, industry give wish lists for changes to Office of Oncology Excellence, but Commissioner Scott Gottlieb will ultimately determine who gets what.
Drug Review Cancer

2016 Review: Refocus, Reduce, Reform The Watchwords In Japan

While reimbursement pricing issues and policies dominated the Japanese pharma market in 2016, there was also notable commercial activity during the year, although this was more about refocusing and reducing rather than major mergers and acquisitions.

Japan Commercial

2016 Review: Price Pressure Marks A Turbulent Year In Japan

If one theme dominated the Japanese pharma market in 2016 it was reimbursement pricing, with the regular price cuts in April being followed by political pressure over high-priced oncology drugs, and then major new reforms by the end of the year.

Japan Policy

Deals Shaping the Medical Industry, October 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in September 2016.

Deals BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Cardiovascular
  • Gastrointestinal
  • Immune Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Lupin Ltd.
  • Senior Management
  • Ray Tsunoda, Pres.
  • Contact Info
  • Kyowa Pharmaceutical Industry Co. Ltd.
    Phone: (81)
    5-13-9 Nishinakajima
    Yodogawa-ku
    Osaka, 532-0011
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register